Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient.

In the clinical setting, bleeding is a common manifestation of acute promyelocytic leukemia (APL), whereas thrombosis is relatively rare, especially as an initial symptom. Here, we report an unusual case of APL with acute myocardial infarction as the first manifestation and cerebral infarction as the relapse manifestation in a healthy young woman. This unique case emphasizes that a thrombotic event could be the first manifestation of an underlying hematological disorder such as APL and could also be a sign of relapse. Rapid detection of the underlying disorder and the timely use of anticoagulation therapy and ATRA are crucial for preventing further deterioration of the disease and saving the patient's life.

[1]  A. Rashidi,et al.  Thrombosis in acute promyelocytic leukemia. , 2013, Thrombosis research.

[2]  L. Shih,et al.  Acute Promyelocytic Leukemia-Associated Thrombosis , 2013, Acta Haematologica.

[3]  S. Jain,et al.  Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis. , 2012, Texas Heart Institute journal.

[4]  J. Jefferies,et al.  Prompt Recognition and Percutaneous Coronary Intervention Leads to Favorable Myocardial Recovery After ST-Segment Elevation Myocardial Infarction Secondary to Acute Promyelocytic Leukemia: Pediatric Case Report , 2012, Pediatric Cardiology.

[5]  T. Cahill,et al.  Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging. , 2011, Circulation.

[6]  W. Maier,et al.  Intracoronary thrombus with tissue factor expression heralding acute promyelocytic leukaemia. , 2007, European heart journal.

[7]  Jie Jin,et al.  Simultaneous presentation of acute myocardial infarction and acute promyelocytic leukemia , 2006, Annals of Hematology.

[8]  T. Südhoff,et al.  Retinoic acid in the treatment of acute promyelocytic leukemia: Inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events , 1992, Annals of Hematology.

[9]  K. Miller,et al.  Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction. , 2000, Blood.

[10]  S. Yonekura,et al.  Cerebellar infarction with hypertriglyceridemia during all-trans retinoic acid therapy for acute promyelocytic leukemia. , 1995, Leukemia.

[11]  E. Archimbaud,et al.  Successful systemic thrombolysis of hepatic vein thrombosis in a patient with promyelocytic leukemia treated with all‐trans retinoic acid , 1995, American journal of hematology.

[12]  B. Dhabhar,et al.  Acute promyelocytic leukemia with ischaemic events. , 1993, Journal of Association of Physicians of India.

[13]  C. Aul,et al.  All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia [letter; comment] , 1992 .

[14]  C. Aul,et al.  All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia. , 1992, Blood.

[15]  P. Atkinson,et al.  Acute promyelocytic leukaemia associated with acute myocardial infarction. A case report. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[16]  G. Suzzi,et al.  [Acute myocardial infarct as the first manifestation of acute myeloid leukemia. Description of an anatomo-clinical case]. , 1980, Giornale italiano di cardiologia.